RecruitingNot ApplicableNCT07219108

Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU

The TAVERN Trial: Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU - A Study of Clinical Outcomes and Cost Reduction


Sponsor

Washington University School of Medicine

Enrollment

160 participants

Start Date

Sep 24, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This study will demonstrate the impact of taVNS on reducing adverse events in NeuroICU patients, determine if taVNS reduces length of stay, and quantify the economic benefits of taVNS implementation in a broader neurocritical care population.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Auricular Vagus Nerve Stimulation and a medical device called Sham Auricular Vagus nerve Stimulation for people with acute medical conditions and acute neurological injury. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAuricular Vagus Nerve Stimulation

Transcutaneous auricular vagal nerve stimulation

DEVICESham Auricular Vagus nerve Stimulation

Transcutaneous auricular vagal nerve ear clip applied without current/stimulation


Locations(1)

Washington University School of Medicine

St Louis, Missouri, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07219108


Related Trials